UBS Group’s Stride LRN Stock Holding History

UBS Group’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,500	Closed	-$3.05M	–	10909
2025 Q3	$3.05M	Buy	+20,500	New	+$3.01M	﹤0.01%	4536

Other funds holding LRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

UBS Group's LRN Position: Q2 2026 in Review

UBS Group reduced its Stride (LRN) stake by 11% in Q2 2026, selling an estimated $6.01M and leaving 530,833 shares worth $45.8M. The position accounts for 0.01% of the portfolio, ranked #1833.

UBS Group first reported a position in LRN in Q4 2014 and has held it in 45 quarters since. The position peaked at $144M in Q2 2025. 414 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

UBS Group held 530,833 shares of Stride worth $45.8M as of Q2 2026.
UBS Group sold 65,354 Stride shares in Q2 2026, an estimated $6.01M.
Stride made up 0.01% of UBS Group's portfolio in Q2 2026, its #1833 holding.
UBS Group first reported a position in Stride in Q4 2014 and has held it in 45 quarters since.
UBS Group's Stride position peaked at $144M in Q2 2025.
414 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.